Angkana Herunsalee
Thailand Ministry of Public Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Angkana Herunsalee.
International Immunopharmacology | 2010
Warisara Parichatikanond; Chuthamanee Suthisisang; Panadda Dhepakson; Angkana Herunsalee
In inflammation, the responses to noxious stimuli are controlled by the highly modulated interactions between various immune cells and chemical mediators. The purpose of this study is to evaluate and compare the anti-inflammatory effect of diterpenoids isolated from Andrographis paniculata, including dehydroandrographolide (AP1), andrographolide (AP2) and neoandrographolide (AP3), on the production of inflammatory cytokines and COX activities. Furthermore, the alteration of gene expression involved in this activity was investigated in the most potent compound to elucidate the other possible molecular mechanisms. AP1 (30.1 μM; 10 μg/ml) and AP2 (28.5 μM; 10 μg/ml) markedly inhibited COX-1 in ionophore A23187-induced human platelets. AP2 (28.5 μM) and AP3 (20.8 μM; 10 μg/ml) strongly suppressed the LPS-stimulated COX-2 activity in human blood. In addition, AP2 modulated the level of LPS-induced TNF-α, IL-6, IL-1β and IL-10 secretion in human blood in a concentration-dependent manner. The results revealed that AP2 exhibited the highest efficacy. Therefore, changes in the levels of mRNA transcripts by AP2 were further measured using human cDNA microarrays. The molecular response to AP2 was complex and mediated by various processes. Among the altered gene expressions, the genes involved in immune and inflammation processes were selectively down-regulated, such as cytokines and cytokine receptors (TNFSF14, TNF, TNFRSF6, and IL1A), chemokines (CCL8 and CXCL11), JAK/STAT signaling (JAK3 and STAT5A), TLRs family (TLR4 and TLR8) and NF-κB (NFKB1). Expression of some genes was validated using RT-PCR. The results demonstrated that AP1, AP2 and AP3 exhibited the anti-inflammatory effect by interfering COX and inflammatory cytokines and the underlying mechanisms of AP2 may be related to down-expression of genes involved in inflammatory cascade.
Fitoterapia | 2008
Suvara K. Wattanapitayakul; Linda Chularojmontri; Angkana Herunsalee; Suphan Charuchongkolwongse; Nuchattra Chansuvanich
The ethanolic extract of Kaempferia parviflora (KP) rhizomes dose-dependently relaxed both aortic rings and ileum precontracted with phenylephrine and acethylcholine, respectively.
Pharmaceutical Biology | 2007
Aranya Jutiviboonsuk; Hong-Jie Zhang; Tamara P. Kondratyuk; Angkana Herunsalee; Wongsatit Chaukul; John M. Pezzuto; Harry H. S. Fong; Nuntavan Bunyapraphatsara
Abstract A new plant species, Barringtonia maunwongyathiae. W. Chuakul (Lecythidaceae), was recently discovered in Khuan Thon Forest, Ao Luek District, Krabi Province, Thailand. Chemical investigation of the leaves of this plant led to the isolation of 10 triterpenes, 3 steroids, and a vitamin E derivative. The structures of these compounds were identified as taraxerol (1), 3-(E.)-coumaroyltaraxerol (2), 3-(Z.)-coumaroyltaraxerol (3), 3-(E.)-coumaroyl β.-amyrin (4), 3-(Z.)-coumaroyl β.-amyrin (5), 3-(E.)-coumaroyl α.-amyrin (6), 3-(Z.)-coumaroyl α.-amyrin (7), 3-(E.)-coumaroyllupeol (8), 3-(Z.)-coumaroyllupeol (9), 3,19,24-trihydroxyurs-12-ene-28-oic acid (10), stigma-4,22-dien-3-one (11), β.-stigmasterol (12), 3-O.-β.-D-glucopyranosyl-stigmasta-5,22-diene (13), and α.-tocopherylquinone (14). All compounds were evaluated for their cancer chemopreventive potential based on inhibition of TPA-induced ornithine decarboxylase expression, COX-1 and COX-2 activities, and phorbol ester–induced NF-κB luciferase expression, as well as activation of antioxidant response element–mediated luciferase expression. Compounds 1, 2, and 14 demonstrated greatest promise, while 12 and 13 showed moderate activity.
Basic & Clinical Pharmacology & Toxicology | 2005
Suvara K. Wattanapitayakul; Linda Chularojmontri; Angkana Herunsalee; Suphan Charuchongkolwongse; Somchit Niumsakul; John Anthony Bauer
Biological & Pharmaceutical Bulletin | 2005
Vilasinee Hirunpanich; Anocha Utaipat; Noppawan Phumala Morales; Nuntavan Bunyapraphatsara; Hitoshi Sato; Angkana Herunsalee; Chuthamanee Suthisisang
Biological & Pharmaceutical Bulletin | 2005
Linda Chularojmontri; Suvara K. Wattanapitayakul; Angkana Herunsalee; Suphan Charuchongkolwongse; Somchit Niumsakul; Supatra Srichairat
Journal of Ethnopharmacology | 2007
Suvara K. Wattanapitayakul; Maneewan Suwatronnakorn; Linda Chularojmontri; Angkana Herunsalee; Somchit Niumsakul; Suphan Charuchongkolwongse; Nuchattra Chansuvanich
Journal of Natural Products | 2006
Sudarat Homhual; Nuntavan Bunyapraphatsara; Tamara P. Kondratyuk; Angkana Herunsalee; Wongsatit Chaukul; John M. Pezzuto; Harry H. S. Fong; Hong-Jie Zhang
Planta Medica | 2006
Sudarat Homhual; Hong-Jie Zhang; Nuntavan Bunyapraphatsara; Tamara P. Kondratyuk; Bernard D. Santarsiero; Andrew D. Mesecar; Angkana Herunsalee; Wongsatit Chaukul; John M. Pezzuto; Harry H. S. Fong
Journal of Health Science | 2017
Areerat Khorchai; Budsaba Rerkamnuaychoke; Siripakorn Sangkitporn; Sawitree Duangrueng; Chonlada Yodtup; Somchai Sangkitporn; Angkana Herunsalee